Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Benvenisty, Nissim  [Clear All Filters]
2013
Nissenbaum J, Bar-Nur O, Ben-David E, Benvenisty N. Global Indiscriminate Methylation in Cell-Specific Gene Promoters following Reprogramming into Human Induced Pluripotent Stem Cells. Stem Cell Reports. 2013;1(6):509-17.
Stelzer Y, Ronen D, Bock C, Boyle P, Meissner A, Benvenisty N. Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells. Stem Cell Reports. 2013;1(1):79-89.
Ben-David U, Mayshar Y, Benvenisty N. Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nat Protoc. 2013;8(5):989-97.
2014
Ben-David U, Biran A, Scaffidi P, Herold-Mende C, Boehringer M, Meshorer E, Benvenisty N. Elimination of undifferentiated cancer cells by pluripotent stem cell inhibitors. J Mol Cell Biol. 2014.
Weissbein U, Benvenisty N, Ben-David U. Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol. 2014;204(2):153-63.
Ronen D, Benvenisty N. Sex-Dependent Gene Expression in Human Pluripotent Stem Cells. Cell Rep. 2014.
2015
Stelzer Y, Bar S, Bartok O, Afik S, Ronen D, Kadener S, Benvenisty N. Differentiation of Human Parthenogenetic Pluripotent Stem Cells Reveals Multiple Tissue- and Isoform-Specific Imprinted Transcripts. Cell Rep. 2015.
2016
Weissbein U, Schachter M, Egli D, Benvenisty N. Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq. Nat Commun. 2016;7:12144.
Sagi I, Chia G, Golan-Lev T, Peretz M, Weissbein U, Sui L, Sauer MV, Yanuka O, Egli D, Benvenisty N. Derivation and differentiation of haploid human embryonic stem cells. Nature. 2016.
Halevy T, Biancotti J-C, Yanuka O, Golan-Lev T, Benvenisty N. Molecular Characterization of Down Syndrome Embryonic Stem Cells Reveals a Role for RUNX1 in Neural Differentiation. Stem Cell Reports. 2016.
2018
Braverman-Gross C, Nudel N, Ronen D, Beer NL, McCarty MI, Benvenisty N. Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs. Stem Cell Res. 2018;31:16-26.
Sagi I, Bar S, Benvenisty N. Mice from Same-Sex Parents: CRISPRing Out the Barriers for Unisexual Reproduction. Cell Stem Cell. 2018;23(5):625-627.
2019
Yilmaz A, Benvenisty N. Defining Human Pluripotency. Cell Stem Cell. 2019;25(1):9-22.
Sagi I, De Pinho JC, Zuccaro MV, Atzmon C, Golan-Lev T, Yanuka O, Prosser R, Sadowy A, Perez G, Cabral T, et al. Distinct Imprinting Signatures and Biased Differentiation of Human Androgenetic and Parthenogenetic Embryonic Stem Cells. Cell Stem Cell. 2019;25(3):419-432.e9.
Vershkov D, Fainstein N, Suissa S, Golan-Lev T, Ben-Hur T, Benvenisty N. FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo. Cell Rep. 2019;26(10):2531-2539.e4.
Weissbein U, Peretz M, Plotnik O, Yanuka O, Sagi I, Golan-Lev T, Benvenisty N. Genome-wide Screen for Culture Adaptation and Tumorigenicity-Related Genes in Human Pluripotent Stem Cells. iScience. 2019;11:398-408.
Bar S, Seaton LRoz, Weissbein U, Eldar-Geva T, Benvenisty N. Global Characterization of X Chromosome Inactivation in Human Pluripotent Stem Cells. Cell Rep. 2019;27(1):20-29.e3.
2020
Avior Y, Lezmi E, Eggan K, Benvenisty N. Cancer-Related Mutations Identified in Primed Human Pluripotent Stem Cells. Cell Stem Cell. 2020.
Lezmi E, Weissbein U, Golan-Lev T, Nissim-Rafinia M, Meshorer E, Benvenisty N. The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation. Stem Cell Reports. 2020.
2021
Keshet G, Benvenisty N. Large-scale analysis of imprinting in naive human pluripotent stem cells reveals recurrent aberrations and a potential link to FGF signaling. Stem Cell Reports. 2021.
2022
Sarel-Gallily R, Golan-Lev T, Yilmaz A, Sagi I, Benvenisty N. Genome-wide analysis of haploinsufficiency in human embryonic stem cells. Cell Rep. 2022;38(13):110573.
Vershkov D, Yilmaz A, Yanuka O, Nielsen ALade, Benvenisty N. Genome-wide screening for genes involved in the epigenetic basis of fragile X syndrome. Stem Cell Reports. 2022.
Rozanska A, Cerna-Chavez R, Queen R, Collin J, Zerti D, Dorgau B, Beh CShyan, Davey T, Coxhead J, Hussain R, et al. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation. Stem Cells Transl Med. 2022.
2023
Pagis A, Alfi O, Kinreich S, Yilmaz A, Hamdan M, Gadban A, Panet A, Wolf DG, Benvenisty N. Genome-wide loss-of-function screen using human pluripotent stem cells to study virus-host interactions for SARS-CoV-2. Stem Cell Reports. 2023;18(9):1766-1774.
Segal E, Nissenbaum J, Peretz M, Golan-Lev T, Cashman R, Philip H, Reubinoff BE, Kopper O, Benvenisty N. Genome-wide screen for anticancer drug resistance in haploid human embryonic stem cells. Cell Prolif. 2023:e13475.

Pages